Bottles of Similac baby formula from Abbott Laboratories are visible in a shipment box, in Lafayette, California, May 13, 2022.
Shortages of baby formula were reported in early 2022. (Smith Collection/Gado/Getty Images) WASHINGTON - Abbott Laboratories is under investigation by the Food and Drug Administration (FDA) following a recent report of another baby’s death potentially connected to Abbott formula.
The baby died in January after consuming Abbott formula, and the FDA said in a release Wednesday they learned about the child’s death from a June 10 consumer complaint.